Covid-19: Israeli data supports Pfizer vaccine effectiveness

Covid-19: Israeli data supports Pfizer vaccine effectiveness
Credit: Pfizer, BioNTech

Fewer than 0.01% of people who received Pfizer's COVID-19 vaccine have contracted the virus more than a week after receiving the second dose, a leading Israeli healthcare provider said on Monday. The preliminary results shared by Israeli HMO Maccabi showed that only 20 people out of some 128,600 who received both shots have since been infected with the COVID-19 virus. Israel is a world leader with its rapid vaccine rollout, though the data also comes during a nationwide lockdown that has been helping to stem contagion. All patients experienced a mild illness with symptoms including headaches, cough, weakness or fatigue.

co-founder of Pendect. Trying to protect free speech and democracies by creating a global news platform that is built through expert contribution. In love with vinyl, psytrance and penguins.
Card reviewed by: @ericof